You are here

Study Evaluating the Etiology of Intra-Abdominal Infections

Last updated on December 6, 2018

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Intra-abdominal Infection
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that
will be positive for enterococcus or an enterococcal bacteriemia in association with
an intra-abdominal source of infection.

- A control will be defined as a culture-positive intra-abdominal infection or
bacteriemia due to an intraabdominal focus where enterococci have not been isolated.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details
NCT00244088
Pfizer
Completed
Study Evaluating the Etiology of Intra-Abdominal Infections

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

HIV Infections, Peripheral Neuropathy
NCT00232141
All Genders
18+
Years
Multiple Sites
Cerebral Toxoplasmosis, HIV Infections
NCT00000966
All Genders
13+
Years
Multiple Sites
Bacterial Infection
NCT00939562
Males
18+
Years
Ahmedabad, Gujarat
Study Evaluating the Etiology of Intra-Abdominal Infections
Study of the Etiology of Intra-Abdominal Infections
The aim of this study is to define the etiology of intra-abdominal infections, to study the role of Enterococcus spp and Pseudomonas aeruginosa in these infections and to clarify the need for specific enterococcal antimicrobial coverage.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Intra-abdominal fluid
Non-Probability Sample
Surgery units
Intra-abdominal Infection
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
340
December 2004
December 2004   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • A case will be defined as an intra-abdominal abscess or peritoneal fluid culture that will be positive for enterococcus or an enterococcal bacteriemia in association with an intra-abdominal source of infection.
  • A control will be defined as a culture-positive intra-abdominal infection or bacteriemia due to an intraabdominal focus where enterococci have not been isolated.

Exclusion Criteria:

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00244088
101316
Not Provided
Not Provided
Not Provided
Not Provided
Wyeth is now a wholly owned subsidiary of Pfizer
Not Provided
Principal Investigator: Medical Monitor Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer
August 2009

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now